ArticleMolecular cancer therapeutics2020

A Novel Approach to Safer Glucocorticoid Receptor-Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition.

Ekaterina A Lesovaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.